IL-17A is a central regulator of lung tumor growth

In a recent study we reported increased expression of IL-17A in the lung of patients with lung adenocarcinoma. Local blockade of IL-17A in the lung, in a model of lung cancer revealed enhanced anti-tumor immunity characterized by increased IFN gamma, a diminished T-regulatory cell number and reduced tumor growth.